Filing Details
- Accession Number:
- 0001455244-13-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-06 15:41:10
- Reporting Period:
- 2013-05-03
- Filing Date:
- 2013-05-06
- Accepted Time:
- 2013-05-06 15:41:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 827809 | Qlt Inc | QLTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1506916 | A Jeffrey Meckler | C/O Qlt Inc. 887 Great Northern Way, Suite 101 Vancouver A1 V5T 4T5 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-03 | 20,000 | $7.96 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.94 to $7.99 inclusive. The reporting person undertakes to provide to QLT Inc., any security holder of QLT Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
